BRPI0816887A2 - Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga - Google Patents

Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga

Info

Publication number: BRPI0816887A2
Authority: BR; Brazil
Prior art keywords: delivery system; drug delivery; treat; manufacture; prevent
Prior art date: 2007-09-21

Application number

Other languages

English (en)

Inventor

Wouter De Graaff

Raymond Zeeman

Original Assignee

Organon Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-21

Filing date

2008-09-22

Publication date

2015-03-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40329142&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0816887(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-09-22 Application filed by Organon Nv filed Critical Organon Nv

2015-03-24 Publication of BRPI0816887A2 publication Critical patent/BRPI0816887A2/pt

2016-01-12 Publication of BRPI0816887A8 publication Critical patent/BRPI0816887A8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
- A61F6/142—Wirelike structures, e.g. loops, rings, spirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gynecology & Obstetrics (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Dermatology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)

BRPI0816887A 2007-09-21 2008-09-22 Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga BRPI0816887A8 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07018584		2007-09-21
PCT/EP2008/007975 WO2009036999A1 (en)	2007-09-21	2008-09-22	Drug delivery system

Publications (2)

Publication Number	Publication Date
BRPI0816887A2 true BRPI0816887A2 (pt)	2015-03-24
BRPI0816887A8 BRPI0816887A8 (pt)	2016-01-12

Family

ID=40329142

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0816887A BRPI0816887A8 (pt)	2007-09-21	2008-09-22	Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga

Country Status (19)

Country	Link
US (2)	US8741329B2 (pt)
EP (1)	EP2200547A1 (pt)
JP (1)	JP5380452B2 (pt)
KR (2)	KR20150046323A (pt)
CN (1)	CN101827569B (pt)
AR (1)	AR066166A1 (pt)
AU (1)	AU2008300825B2 (pt)
BR (1)	BRPI0816887A8 (pt)
CA (1)	CA2699266C (pt)
CL (1)	CL2008002810A1 (pt)
CO (1)	CO6260045A2 (pt)
EC (1)	ECSP10010079A (pt)
MX (1)	MX2010003107A (pt)
MY (1)	MY163892A (pt)
NZ (1)	NZ583874A (pt)
RU (1)	RU2488369C2 (pt)
TW (1)	TW200930343A (pt)
WO (1)	WO2009036999A1 (pt)
ZA (1)	ZA201002014B (pt)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0222522D0 (en)	2002-09-27	2002-11-06	Controlled Therapeutics Sct	Water-swellable polymers
GB0417401D0 (en)	2004-08-05	2004-09-08	Controlled Therapeutics Sct	Stabilised prostaglandin composition
US8900620B2 (en)	2005-10-13	2014-12-02	DePuy Synthes Products, LLC	Drug-impregnated encasement
GB0613333D0 (en) *	2006-07-05	2006-08-16	Controlled Therapeutics Sct	Hydrophilic polyurethane compositions
GB0613638D0 (en) *	2006-07-08	2006-08-16	Controlled Therapeutics Sct	Polyurethane elastomers
WO2008007098A2 (en) *	2006-07-12	2008-01-17	Controlled Therapeutics (Scotland) Ltd.	Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) *	2006-10-18	2006-11-29	Controlled Therapeutics Sct	Bioresorbable polymers
BRPI1009586A2 (pt)	2009-03-17	2016-03-08	Intervet Int Bv	sistema de administração de medicamento zootécnico, e, método para aprimorar o crescimento e ganho de peso em animais de criação
US8568374B2 (en) *	2009-05-04	2013-10-29	Merck Sharp & Dohme B.V.	Intrauterine system
FI20095563A7 (fi) *	2009-05-20	2010-11-21	Bayer Schering Pharma Oy	Vaginaalinen antojärjestelmä
AU2010256558B2 (en)	2009-06-03	2013-10-03	Forsight Labs, Llc	Anterior segment drug delivery
PL2547332T3 (pl) *	2010-03-16	2019-07-31	Titan Pharmaceuticals, Inc.	Heterogeniczne wyroby wszczepialne do podaży leku
DE102010003494A1 (de) *	2010-03-31	2011-10-06	Bayer Schering Pharma Aktiengesellschaft	Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
US10849857B2 (en)	2010-07-28	2020-12-01	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es)	2010-06-29	2012-10-10	Leon Farma Sa Lab	Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en)	2010-07-28	2022-06-07	Laboratorios Leon Farma Sa	Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en)	2010-07-28	2017-03-28	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US8580294B2 (en)	2010-10-19	2013-11-12	International Partnership For Microbicides	Platinum-catalyzed intravaginal rings
EP2717813B1 (en) *	2011-06-06	2020-05-20	Auritec Pharmaceuticals	Drug delivery device employing wicking release window
RU2740680C2 (ru)	2011-09-14	2021-01-19	Форсайт Вижн5, Инк.	Глазное вкладочное устройство и способы
RS62297B1 (sr)	2011-11-23	2021-09-30	Therapeuticsmd Inc	Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
TWI590843B (zh)	2011-12-28	2017-07-11	信迪思有限公司	膜及其製造方法
AR089765A1 (es) *	2012-01-23	2014-09-17	Bayer Oy	Un sistema para el suministro de un farmaco
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
EP2911623B1 (en)	2012-10-26	2019-08-14	Forsight Vision5, Inc.	Ophthalmic system for sustained release of drug to eye
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
AU2014281010B2 (en)	2013-06-21	2018-05-10	DePuy Synthes Products, Inc.	Films and methods of manufacture
US10137031B2 (en)	2013-11-14	2018-11-27	International Partnership For Microbicides, Inc.	Combination therapy intravaginal rings
US10596103B2 (en)	2013-12-11	2020-03-24	Merek Sharp & Dohme B.V.	Drug delivery system for delivery of anti-virals
US10413504B2 (en)	2013-12-11	2019-09-17	Merck Sharp & Dohme Corp.	Intravaginal ring drug delivery system
RU2016143081A (ru)	2014-05-22	2018-06-26	Терапьютиксмд, Инк.	Натуральные комбинированные гормонозаместительные составы и терапии
US20160296532A1 (en)	2015-04-13	2016-10-13	Forsight Vision5, Inc.	Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
EP3393452B1 (en) *	2015-12-21	2021-08-04	Bayer Oy	Method for manufacturing a drug delivery device
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
US9931349B2 (en)	2016-04-01	2018-04-03	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
US10406336B2 (en)	2016-08-03	2019-09-10	Neil S. Davey	Adjustable rate drug delivery implantable device
US11766400B2 (en) *	2016-10-24	2023-09-26	Yale University	Biodegradable contraceptive implants
WO2019222856A1 (en)	2018-05-24	2019-11-28	Nureva Inc.	Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
AU2019275406B2 (en)	2018-05-24	2024-11-14	Celanese Eva Performance Polymers Llc	Implantable device for sustained release of a macromolecular drug compound
WO2019226519A1 (en)	2018-05-24	2019-11-28	Celanese EVA Performance Polymers Corporation	Implantable device for sustained release of a macromolecular drug compound
US20200179274A1 (en) *	2018-12-11	2020-06-11	Lupin Inc.	Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof
DE102019115343A1 (de) *	2019-06-06	2020-12-10	EVESTRA GmbH	Vaginalring für die hormonelle Kontrazeption
WO2022231930A1 (en)	2021-04-26	2022-11-03	Celanese Eva Performance Polymers Llc	Implantable device for sustained release of a macromolecular drug compound
EP4215181A1 (en) *	2022-01-21	2023-07-26	Sever Pharma Solutions	An intravaginal ring
EP4215180A1 (en) *	2022-01-21	2023-07-26	Sever Pharma Solutions	A drug delivery system
EP4487840A1 (en)	2023-07-07	2025-01-08	Sever Pharma Solutions	A three-layered intravaginal ring

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3545439A (en)	1968-01-04	1970-12-08	Upjohn Co	Medicated devices and methods
US3854480A (en) *	1969-04-01	1974-12-17	Alza Corp	Drug-delivery system
US3995633A (en)	1975-12-02	1976-12-07	The Procter & Gamble Company	Vaginal Medicament dispensing device
US3995634A (en)	1975-12-02	1976-12-07	The Procter & Gamble Company	Vaginal cavity dispensing means and method
US4237885A (en)	1978-10-23	1980-12-09	Alza Corporation	Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en)	1978-12-29	1981-10-06	The Population Council, Inc.	Intravaginal ring
DE3040978A1 (de)	1980-10-28	1982-05-27	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Vaginalring
US4629449A (en)	1982-07-29	1986-12-16	Alza Corporation	Vaginal dispenser for dispensing beneficial hormone
EP0180264A1 (en)	1984-10-12	1986-05-07	Akzo N.V.	Release system for two or more active substances
ES2054784T3 (es)	1987-08-08	1994-08-16	Akzo Nv	Un metodo para la fabricacion de un implante.
AU3432689A (en)	1988-03-24	1989-10-16	Bukh Meditec A/S	Controlled release composition
DK606288D0 (da) *	1988-03-24	1988-10-31	Bukh Meditec	Praeparat
US5766632A (en)	1993-10-01	1998-06-16	Legere Pharmaceuticals, Ltd.	Method of using lectins for contraception
JP3720386B2 (ja) *	1993-12-27	2005-11-24	住友製薬株式会社	薬物放出制御製剤
US6544546B1 (en)	1995-07-04	2003-04-08	Akzo Nobel, N.V.	Ring-shaped devices
US5972372A (en) *	1996-07-31	1999-10-26	The Population Council, Inc.	Intravaginal rings with insertable drug-containing core
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
IL123813A0 (en)	1997-04-11	1998-10-30	Akzo Nobel Nv	Drug delivery system for two or more active substances
DE69817017T2 (de)	1997-12-12	2004-02-26	Akzo Nobel N.V.	Verpackung für einen vaginalring
WO1999031137A1 (en) *	1997-12-18	1999-06-24	Eli Lilly And Company	Crystalline teriparatide
TW586944B (en)	1998-05-29	2004-05-11	Sumitomo Pharma	Controlled release agent having a multi-layer structure
US6579533B1 (en)	1999-11-30	2003-06-17	Bioasborbable Concepts, Ltd.	Bioabsorbable drug delivery system for local treatment and prevention of infections
US6476079B1 (en) *	1999-12-23	2002-11-05	Leiras Oy	Devices for the delivery of drugs having antiprogestinic properties
CA2442281C (en)	2001-03-27	2010-06-08	Galen (Chemicals) Limited	Intravaginal drug delivery devices for the administration of an antimicrobial agent
CA2451187C (en)	2001-06-22	2012-08-14	Southern Biosystems, Inc.	Zero-order prolonged release coaxial implants
CN1289064C (zh) *	2001-08-31	2006-12-13	先灵有限责任公司	药物输送体系
CA2447984A1 (en)	2001-09-28	2003-04-03	Mcneil-Ppc, Inc.	Dosage forms having an inner core and outer shell with different shapes
US6992219B2 (en) *	2002-08-09	2006-01-31	Cephalon France	Modafinil polymorphic forms
TWI336627B (en)	2003-05-23	2011-02-01	Organon Nv	Drug delivery system,and use and manufacturing method thereof
CA2531640C (en) *	2003-07-10	2013-06-18	Galen (Chemicals) Limited	Intravaginal drug delivery devices
US8481079B2 (en)	2004-03-24	2013-07-09	Merck Sharp & Dohme B.V.	Drug delivery system based on polyethylene vinylacetate copolymers
TW200727920A (en)	2005-06-21	2007-08-01	Organon Nv	New regimens for oral monophasic contraceptives
US20080242650A1 (en)	2007-03-26	2008-10-02	Jean-Louis Thomas	Oral contraceptive regimen
EP2207529B1 (en) *	2007-09-07	2014-12-31	Mati Therapeutics Inc.	Drug cores for sustained release of therapeutic agents

2008
- 2008-09-19 AR ARP080104075A patent/AR066166A1/es unknown
- 2008-09-19 TW TW097136144A patent/TW200930343A/zh unknown
- 2008-09-19 US US12/234,261 patent/US8741329B2/en active Active
- 2008-09-22 JP JP2010525267A patent/JP5380452B2/ja not_active Expired - Fee Related
- 2008-09-22 CL CL2008002810A patent/CL2008002810A1/es unknown
- 2008-09-22 CA CA2699266A patent/CA2699266C/en not_active Expired - Fee Related
- 2008-09-22 MX MX2010003107A patent/MX2010003107A/es active IP Right Grant
- 2008-09-22 RU RU2010115785/14A patent/RU2488369C2/ru not_active IP Right Cessation
- 2008-09-22 BR BRPI0816887A patent/BRPI0816887A8/pt not_active IP Right Cessation
- 2008-09-22 CN CN2008801122070A patent/CN101827569B/zh not_active Expired - Fee Related
- 2008-09-22 WO PCT/EP2008/007975 patent/WO2009036999A1/en not_active Ceased
- 2008-09-22 KR KR20157008074A patent/KR20150046323A/ko not_active Ceased
- 2008-09-22 MY MYPI2010001185A patent/MY163892A/en unknown
- 2008-09-22 NZ NZ583874A patent/NZ583874A/en not_active IP Right Cessation
- 2008-09-22 KR KR1020107008582A patent/KR20100085054A/ko not_active Ceased
- 2008-09-22 EP EP08802471A patent/EP2200547A1/en not_active Withdrawn
- 2008-09-22 AU AU2008300825A patent/AU2008300825B2/en not_active Ceased
2010
- 2010-03-19 CO CO10033049A patent/CO6260045A2/es not_active Application Discontinuation
- 2010-03-19 ZA ZA2010/02014A patent/ZA201002014B/en unknown
- 2010-03-31 EC EC2010010079A patent/ECSP10010079A/es unknown
2013
- 2013-10-31 US US14/068,233 patent/US20140056962A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2699266C (en)	2016-08-30
US20140056962A1 (en)	2014-02-27
JP5380452B2 (ja)	2014-01-08
BRPI0816887A8 (pt)	2016-01-12
CL2008002810A1 (es)	2009-06-05
CO6260045A2 (es)	2011-03-22
AU2008300825B2 (en)	2013-06-06
MX2010003107A (es)	2010-04-21
EP2200547A1 (en)	2010-06-30
ZA201002014B (en)	2010-11-24
CN101827569B (zh)	2013-10-16
AR066166A1 (es)	2009-07-29
CN101827569A (zh)	2010-09-08
WO2009036999A1 (en)	2009-03-26
MY163892A (en)	2017-11-15
US20090081278A1 (en)	2009-03-26
ECSP10010079A (es)	2010-04-30
AU2008300825A1 (en)	2009-03-26
US8741329B2 (en)	2014-06-03
KR20150046323A (ko)	2015-04-29
RU2488369C2 (ru)	2013-07-27
CA2699266A1 (en)	2009-03-26
NZ583874A (en)	2012-04-27
KR20100085054A (ko)	2010-07-28
RU2010115785A (ru)	2011-10-27
TW200930343A (en)	2009-07-16
JP2010539205A (ja)	2010-12-16

Publication	Publication Date	Title
BRPI0816887A8 (pt)	2016-01-12	Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga
BRPI0811262A2 (pt)	2014-11-04	Composto, composto ou sal do mesmo, composição farmacêutica, modulador de receptor de glicocorticóide, método para prevenção e/ou tratamento de bistúrbios metabólicos, doenças inflamatórias, doenças auto-imunes, doenças alérgicas, doenças do sistema nervoso central, doenças cardiovasculares, doenças relacionadas com homeostase ou glaucoma, e uso de pelo menos um composto ou um sal do mesmo
EP2313084A4 (en)	2014-03-05	INTRAUTERINE DISPOSAL SYSTEM FOR PREVENTION
BRPI0814759A2 (pt)	2015-03-03	Sistema de administração e notificação de medicamento específico de paciente
BRPI0814735A2 (pt)	2019-09-24	sistema adaptado para prover um fluxo de gás para as vias áereas de um paciente, e acoplamento de fluxo.
IL202614A0 (en)	2010-06-30	Intravaginal drug delivery devices for the delivery of macromolecules and water soluble drugs
WO2009048594A3 (en)	2009-07-30	Multicomponent bioactive intravaginal ring
IL243709A0 (en)	2016-04-21	Devices, systems and methods for medicament delivery
BRPI1011220A2 (pt)	2016-03-15	composição farmacêutica, métodos para tratar uma doença ou distúrbio, para administração respiratória de dois ou mais agentes ativos, para administração respiratória de uma combinação de agentes ativos, e, para preparar uma composição adequada.
CL2007001132A1 (es)	2008-05-23	Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
BRPI0806531A2 (pt)	2014-04-22	Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
DOP2007000102A (es)	2007-12-31	Arilimidazolonas y ariltriazolona sustituidas asi como su uso
BRPI0814957A2 (pt)	2015-02-03	Composto, pró-droga, agente farmacêutico, método para a profilaxia ou tratamento de uma doença, distúrbio ou condição, e, uso do composto.
BRPI0716196A2 (pt)	2013-11-12	Sistemas de distribuição de fármacos que compreendem soluções sólidas de fármacos fracamente básicos.
CR11493A (es)	2010-08-23	Sistema de administracion vaginal
BRPI0719060A2 (pt)	2014-02-04	Composto, prodroga, agente farmacêutico, métodos para inibir um receptor de angiotensina ii e/ou ativar um receptor ativado com proliferador de peroxisoma, e para prevenir ou tratar doenças ou condições, e, uso de um composto
WO2012083017A3 (en)	2012-08-23	Controlled release oral dosage forms of poorly soluble drugs and uses thereof
BRPI0818615A2 (pt)	2015-04-07	Sistema de aspiração para remoção de líquido descarregado pelo corpo humano, e sensor de líquido para o mesmo.
BRPI0913697A2 (pt)	2016-10-11	lesão de medula, inflamação e doença auto-imuni: agentes teraupêuticos de liberação local controlada.
BRPI1009860A2 (pt)	2016-03-08	composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
ECSP088097A (es)	2008-02-20	Nuevos regímenes para dispositivos de administración controlada de fármacos para anticoncepción
BRPI1009392A2 (pt)	2016-03-08	"formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
CL2007001724A1 (es)	2008-05-09	Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
BRPI0908124A2 (pt)	2015-08-04	Composto, ativador de glucoquinase, composição farmacêutica, uso de um composto ou sal farmacologicamente aceitavél do mesmo, e, métodos de ativação da glucoquinase, e para tratar e/ou prevenir uma doença
CL2013001564A1 (es)	2014-05-02	Metodo para tratar sobrepeso u obesidad que comprende administrar naltrexona y bupropion; metodo para incrementar la biodisponibilidad de naltrexona y bupropion en una terapia combinada; uso de naltrexona y bupropion para tratar sobrepeso u obesisdad e incrementar la biodisponibilidad de estos farmacos; composicion farmaceutica.

Legal Events

Date	Code	Title	Description
2016-01-12	B25A	Requested transfer of rights approved	Owner name: MSD OSS B.V. (NL)
2018-03-20	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2018-07-17	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-11-06	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2480 DE 17-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.